Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics
Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade...
Gespeichert in:
Veröffentlicht in: | Leukemia & lymphoma 1996, Vol.21 (1-2), p.131-136 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 136 |
---|---|
container_issue | 1-2 |
container_start_page | 131 |
container_title | Leukemia & lymphoma |
container_volume | 21 |
creator | Economopoulos, Theofanis Asprou, Niki Stathakis, Nicholas Papageorgiou, Efstathios Dervenoulas, John Xanthaki, Katiana Raptis, Sotos |
description | Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different.
We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se. |
doi_str_mv | 10.3109/10428199609067590 |
format | Article |
fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_3109_10428199609067590</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78524361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVoSfP1A3Io-NSc3EqyZUltLmFJmsCSFtKezViSY6WytJHktPvv42WXQCjtaWZ4PxgehE4J_lgRLD8RXFNBpGywxA1nEu-hA4KpLGmNqzebvablbKjfocOUHjDGTDZ0H-0LiTkV-ACZ79GOENfF5Z8cwQcNrrgNvrwO-v6X9WepWK7H1RBGKKwvLvTkcvpcLJz1VoUV5CG4cG_VnAKvi7spPtmn-VgMEEFlE23KVqVj9LYHl8zJbh6hn1eXPxbX5fLb15vFxbJUdcNzKRUTvGGS0cqIDksFTdVzzgStO2kawfpeKK2okbiilGlaMwlgOOm6XnNg1RH6sO1dxfA4mZTb0SZlnANvwpRaLhitq4bMRrI1qhhSiqZvV1sOLcHtBm37F9o5835XPnWj0S-JHctZP9_q1vchjvA7RKfbDGsXYj-zVTZtqv9d_-VVfDDg8qAgmvYhTNHP3P7z3DP2J5pG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78524361</pqid></control><display><type>article</type><title>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</title><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><source>Taylor & Francis Journals Complete</source><creator>Economopoulos, Theofanis ; Asprou, Niki ; Stathakis, Nicholas ; Papageorgiou, Efstathios ; Dervenoulas, John ; Xanthaki, Katiana ; Raptis, Sotos</creator><creatorcontrib>Economopoulos, Theofanis ; Asprou, Niki ; Stathakis, Nicholas ; Papageorgiou, Efstathios ; Dervenoulas, John ; Xanthaki, Katiana ; Raptis, Sotos</creatorcontrib><description>Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different.
We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.</description><identifier>ISSN: 1042-8194</identifier><identifier>EISSN: 1029-2403</identifier><identifier>DOI: 10.3109/10428199609067590</identifier><identifier>PMID: 8907280</identifier><language>eng</language><publisher>United States: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; extranodal ; Female ; Follow-Up Studies ; Humans ; Lymph Nodes - pathology ; Lymphoma ; Lymphoma, Non-Hodgkin - mortality ; Lymphoma, Non-Hodgkin - pathology ; Lymphoma, Non-Hodgkin - therapy ; Male ; Middle Aged ; Neoplasm Staging ; non-Hodgkin's ; Prognosis ; Sex Factors</subject><ispartof>Leukemia & lymphoma, 1996, Vol.21 (1-2), p.131-136</ispartof><rights>1996 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1996</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</citedby><cites>FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/10428199609067590$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/10428199609067590$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,4024,27923,27924,27925,59647,59753,60436,60542,61221,61256,61402,61437</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8907280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Economopoulos, Theofanis</creatorcontrib><creatorcontrib>Asprou, Niki</creatorcontrib><creatorcontrib>Stathakis, Nicholas</creatorcontrib><creatorcontrib>Papageorgiou, Efstathios</creatorcontrib><creatorcontrib>Dervenoulas, John</creatorcontrib><creatorcontrib>Xanthaki, Katiana</creatorcontrib><creatorcontrib>Raptis, Sotos</creatorcontrib><title>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</title><title>Leukemia & lymphoma</title><addtitle>Leuk Lymphoma</addtitle><description>Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different.
We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Combined Modality Therapy</subject><subject>extranodal</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphoma</subject><subject>Lymphoma, Non-Hodgkin - mortality</subject><subject>Lymphoma, Non-Hodgkin - pathology</subject><subject>Lymphoma, Non-Hodgkin - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>non-Hodgkin's</subject><subject>Prognosis</subject><subject>Sex Factors</subject><issn>1042-8194</issn><issn>1029-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVoSfP1A3Io-NSc3EqyZUltLmFJmsCSFtKezViSY6WytJHktPvv42WXQCjtaWZ4PxgehE4J_lgRLD8RXFNBpGywxA1nEu-hA4KpLGmNqzebvablbKjfocOUHjDGTDZ0H-0LiTkV-ACZ79GOENfF5Z8cwQcNrrgNvrwO-v6X9WepWK7H1RBGKKwvLvTkcvpcLJz1VoUV5CG4cG_VnAKvi7spPtmn-VgMEEFlE23KVqVj9LYHl8zJbh6hn1eXPxbX5fLb15vFxbJUdcNzKRUTvGGS0cqIDksFTdVzzgStO2kawfpeKK2okbiilGlaMwlgOOm6XnNg1RH6sO1dxfA4mZTb0SZlnANvwpRaLhitq4bMRrI1qhhSiqZvV1sOLcHtBm37F9o5835XPnWj0S-JHctZP9_q1vchjvA7RKfbDGsXYj-zVTZtqv9d_-VVfDDg8qAgmvYhTNHP3P7z3DP2J5pG</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Economopoulos, Theofanis</creator><creator>Asprou, Niki</creator><creator>Stathakis, Nicholas</creator><creator>Papageorgiou, Efstathios</creator><creator>Dervenoulas, John</creator><creator>Xanthaki, Katiana</creator><creator>Raptis, Sotos</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</title><author>Economopoulos, Theofanis ; Asprou, Niki ; Stathakis, Nicholas ; Papageorgiou, Efstathios ; Dervenoulas, John ; Xanthaki, Katiana ; Raptis, Sotos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-9c587659523e8b09ca63f775824b9e685ff8cdc2e903225d2459aae71bbfd7a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Combined Modality Therapy</topic><topic>extranodal</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphoma</topic><topic>Lymphoma, Non-Hodgkin - mortality</topic><topic>Lymphoma, Non-Hodgkin - pathology</topic><topic>Lymphoma, Non-Hodgkin - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>non-Hodgkin's</topic><topic>Prognosis</topic><topic>Sex Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Economopoulos, Theofanis</creatorcontrib><creatorcontrib>Asprou, Niki</creatorcontrib><creatorcontrib>Stathakis, Nicholas</creatorcontrib><creatorcontrib>Papageorgiou, Efstathios</creatorcontrib><creatorcontrib>Dervenoulas, John</creatorcontrib><creatorcontrib>Xanthaki, Katiana</creatorcontrib><creatorcontrib>Raptis, Sotos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia & lymphoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Economopoulos, Theofanis</au><au>Asprou, Niki</au><au>Stathakis, Nicholas</au><au>Papageorgiou, Efstathios</au><au>Dervenoulas, John</au><au>Xanthaki, Katiana</au><au>Raptis, Sotos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics</atitle><jtitle>Leukemia & lymphoma</jtitle><addtitle>Leuk Lymphoma</addtitle><date>1996</date><risdate>1996</risdate><volume>21</volume><issue>1-2</issue><spage>131</spage><epage>136</epage><pages>131-136</pages><issn>1042-8194</issn><eissn>1029-2403</eissn><abstract>Among 318 cases of non-Hodgkin's lymphoma (NHL) treated in our unit, 145 (45.6%) had primary extranodal NHL (PE-NHL). The stomach was the most common site (42.1 %), followed by the PE-NHL of the head and neck region. Histologically aggressive histologies (65.5% intermediate and 20.7% high grade) predominated. 89.6% of the cases were localized (stage Ie, 51% and stage II, 38.6%) but 28% had B symptoms. CR was achieved in 82.1 % of the cases. 5-years disease free survival and overall survival were both 65%. Factors that influence prognosis were stage and high grade histology. Among various primary sites the Waldeyer's ring, small intestine and testes had the worse prognosis. Compared to nodal NHL, the PE-NHL were more frequently localized, belonged more often to aggressive histologies and had more often distal extranodal relapses. CR rates and disease free and overall survival were significantly better for PE-NHL. The survival rates, however, listed according to stage and histology for nodal and PE-NHL were not different.
We conclude that although PE-NHL differed from nodal NHL in several respects, prognosis is mainly a factor of stage and histology rather than of the primary localization per se.</abstract><cop>United States</cop><pub>Informa UK Ltd</pub><pmid>8907280</pmid><doi>10.3109/10428199609067590</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1042-8194 |
ispartof | Leukemia & lymphoma, 1996, Vol.21 (1-2), p.131-136 |
issn | 1042-8194 1029-2403 |
language | eng |
recordid | cdi_informahealthcare_journals_10_3109_10428199609067590 |
source | MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete |
subjects | Adolescent Adult Age Factors Aged Aged, 80 and over Combined Modality Therapy extranodal Female Follow-Up Studies Humans Lymph Nodes - pathology Lymphoma Lymphoma, Non-Hodgkin - mortality Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - therapy Male Middle Aged Neoplasm Staging non-Hodgkin's Prognosis Sex Factors |
title | Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A08%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20Extranodal%20Non-Hodgkin's%20Lymphoma%20in%20Adults:%20Clinicopathological%20and%20Survival%20Characteristics&rft.jtitle=Leukemia%20&%20lymphoma&rft.au=Economopoulos,%20Theofanis&rft.date=1996&rft.volume=21&rft.issue=1-2&rft.spage=131&rft.epage=136&rft.pages=131-136&rft.issn=1042-8194&rft.eissn=1029-2403&rft_id=info:doi/10.3109/10428199609067590&rft_dat=%3Cproquest_infor%3E78524361%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78524361&rft_id=info:pmid/8907280&rfr_iscdi=true |